e.l.f. Beauty Earnings Calls
| Release date | May 20, 2026 |
| EPS estimate | $0.290 |
| EPS actual | $0.320 |
| EPS Surprise | 10.34% |
| Revenue estimate | 423.059M |
| Revenue actual | 449.292M |
| Revenue Surprise | 6.20% |
| Release date | Feb 05, 2026 |
| EPS estimate | $0.700 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Feb 04, 2026 |
| EPS estimate | $0.730 |
| EPS actual | $1.24 |
| EPS Surprise | 69.86% |
| Revenue estimate | 461.839M |
| Revenue actual | 489.505M |
| Revenue Surprise | 5.99% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.570 |
| EPS actual | $0.680 |
| EPS Surprise | 19.30% |
| Revenue estimate | - |
| Revenue actual | 343.936M |
Last 4 Quarters for e.l.f. Beauty
Below you can see how ELF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 05, 2025 |
| Price on release | $117.83 |
| EPS estimate | $0.570 |
| EPS actual | $0.680 |
| EPS surprise | 19.30% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $123.11 |
| Oct 31, 2025 | $122.14 |
| Nov 03, 2025 | $120.94 |
| Nov 04, 2025 | $118.29 |
| Nov 05, 2025 | $117.83 |
| Nov 06, 2025 | $76.54 |
| Nov 07, 2025 | $73.74 |
| Nov 10, 2025 | $79.85 |
| Nov 11, 2025 | $77.97 |
| 4 days before | -4.29% |
| 4 days after | -33.83% |
| On release day | -35.04% |
| Change in period | -36.67% |
| Release date | Feb 04, 2026 |
| Price on release | $84.63 |
| EPS estimate | $0.730 |
| EPS actual | $1.24 |
| EPS surprise | 69.86% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $85.03 |
| Jan 30, 2026 | $84.99 |
| Feb 02, 2026 | $86.15 |
| Feb 03, 2026 | $84.81 |
| Feb 04, 2026 | $84.63 |
| Feb 05, 2026 | $76.86 |
| Feb 06, 2026 | $82.09 |
| Feb 09, 2026 | $74.46 |
| Feb 10, 2026 | $73.26 |
| 4 days before | -0.470% |
| 4 days after | -13.43% |
| On release day | -9.18% |
| Change in period | -13.84% |
| Release date | Feb 05, 2026 |
| Price on release | $76.86 |
| EPS estimate | $0.700 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jan 30, 2026 | $84.99 |
| Feb 02, 2026 | $86.15 |
| Feb 03, 2026 | $84.81 |
| Feb 04, 2026 | $84.63 |
| Feb 05, 2026 | $76.86 |
| Feb 06, 2026 | $82.09 |
| Feb 09, 2026 | $74.46 |
| Feb 10, 2026 | $73.26 |
| Feb 11, 2026 | $76.82 |
| 4 days before | -9.57% |
| 4 days after | -0.0520% |
| On release day | 6.80% |
| Change in period | -9.61% |
| Release date | May 20, 2026 |
| Price on release | $50.72 |
| EPS estimate | $0.290 |
| EPS actual | $0.320 |
| EPS surprise | 10.34% |
| Date | Price |
|---|---|
| May 14, 2026 | $55.47 |
| May 15, 2026 | $56.43 |
| May 18, 2026 | $54.86 |
| May 19, 2026 | $52.98 |
| May 20, 2026 | $50.72 |
| May 21, 2026 | $53.12 |
| May 22, 2026 | $52.90 |
| May 26, 2026 | $54.13 |
| May 27, 2026 | $57.36 |
| 4 days before | -8.56% |
| 4 days after | 13.09% |
| On release day | 4.73% |
| Change in period | 3.41% |
e.l.f. Beauty Earnings Call Transcript Summary of Q1 2026
e.l.f. Beauty reported Q1 FY26 results with net sales of $354 million, up 9% year-over-year, adjusted EBITDA of $87 million (up 12%), and 210 basis points of market share gains — marking 26 consecutive quarters of sales growth and share gains. U.S. sales grew 5% while international grew 30%, now representing ~20% of total sales. The company completed the acquisition of Rhode (closed yesterday), which it expects to accelerate brand awareness and distribution (Sephora launch planned in U.S./Canada in September and the U.K. by year-end). Management took a $1 price increase across the portfolio (effective August 1) to help mitigate tariffs; roughly 75% of SKUs remain under $10. Q1 gross margin was 69% (down ~215 bps) due primarily to incremental tariffs; the company is pursuing mitigation via pricing, supply-chain optimization and diversification. They are delaying full-year FY26 guidance pending greater clarity on tariffs; however, they expect first-half adjusted EBITDA margins of ~20%, and they forecast Q2 to reflect more of the higher-tariff cost flow-through, timing of marketing spend, and Rhode’s inclusion (without Sephora sell-in benefit). The balance sheet remains strong ($170M cash; $20M free cash flow in Q1), and management expects the Rhode deal to be accretive over time while investing behind growth (ERP/SAP go-live completed).
Sign In
Buy ELF